Pharmacogenetics of Response to Bisphosphonate Treatment in Postmenopausal Osteoporosis: A Prospective Study
These findings did not support the potential role of VDR BsmI, Col1a1 Sp1, ER1 PvuII, or XbaI polymorphisms in predicting the response to BP therapy in women with postmenopausal OP. Further investigation with larger prospective studies is required.
Authors
- Nesrin Demirsoy (ORCID: https://orcid.org/0000-0003-4332-6118)
- Özden Özyemişçi Taşkıran (ORCID: https://orcid.org/0000-0002-2052-6072)
- Ebru Köseoğlu Tohma (ORCID: https://orcid.org/0000-0002-2578-8661)
- Aylin Sepici Dinçel (ORCID: https://orcid.org/0000-0001-5847-0556)
- Vesile Sepici
- Sirin Akbulut Ayturk
Institutions
- Koç University (TR)
- Dr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi (TR)
- Muğla University (TR)
- Gazi University (TR)
Publication Details
- Journal
- Journal of Bone Metabolism
- Published
- 2025-02-28
- DOI
- https://doi.org/10.11005/jbm.24.787
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 0.00